Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
or

Amplify Weight Loss Drug & Treatment ETF (THNR)

Amplify Weight Loss Drug & Treatment ETF (THNR)
10.52 x 2 27.60 x 2
Post-market by (Cboe BZX)
21.12 +0.46 (+2.23%) 04/24/25 [NYSE Arca]
10.52 x 2 27.60 x 2
Post-market 21.12 unch (unch) 16:10 ET
Quote Overview for Thu, Apr 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
21.02
Day High
21.12
Open 21.04
Previous Close 20.66 20.66
Volume 1,152 1,152
Avg Vol 2,028 2,028
Stochastic %K 75.11% 75.11%
Weighted Alpha -19.94 -19.94
5-Day Change +1.44 (+7.31%) +1.44 (+7.31%)
52-Week Range 18.56 - 28.19 18.56 - 28.19
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Amplify ETFs
  • Assets Under Management 3,098,200
  • Shares Outstanding, K 150
  • 60-Month Beta N/A
  • Price/Earnings ttm N/A
  • Annual Dividend & Yield 0.22 (1.07%)
  • Most Recent Dividend 0.220 on 12/30/24
  • Management Fee 0.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.56 +13.81%
on 04/07/25
Period Open: 22.54
22.18 -4.79%
on 03/25/25
-1.42 (-6.29%)
since 03/24/25
3-Month
18.56 +13.81%
on 04/07/25
Period Open: 23.01
23.71 -10.90%
on 02/25/25
-1.89 (-8.19%)
since 01/24/25

Most Recent Stories

More News
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip

Eli Lilly and Company LLY dropped 6.6% in the Jan. 14 trading session after slashing its revenue guidance for the fourth quarter and fiscal 2024, citing lower-than-expected sales for its weight-loss medicine...

OZEM : 24.23 (+3.11%)
IHE : 66.09 (+1.88%)
LLY : 859.73 (+3.65%)
MEDX : 26.09 (+1.50%)
PPH : 86.09 (+1.43%)
THNR : 21.12 (+2.25%)
The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, PPH, HRTS and THNR

For Immediate ReleaseChicago, IL – October 17, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...

NVO : 62.63 (+2.17%)
LLY : 859.73 (+3.65%)
HRTS : 28.36 (+1.23%)
PPH : 86.09 (+1.43%)
THNR : 21.12 (+2.25%)
Inside the Booming Obesity Drug Market: Weight Loss ETFs to Win

In recent years, the pharmaceutical industry has witnessed a remarkable surge in the development of weight loss medications, particularly GLP-1 receptor agonists such as Ozempic and Wegovy. The global...

NVO : 62.63 (+2.17%)
LLY : 859.73 (+3.65%)
HRTS : 28.36 (+1.23%)
PPH : 86.09 (+1.43%)
THNR : 21.12 (+2.25%)
Tap the Weight-Loss Drug Market With These ETFs

The weight-loss drug market is heating up with the introduction of GLP-1 pills. Novo Nordisk’s NVO Wegovy and Eli Lilly’s LLY Zepbound have been dominating this market and several other companies are...

NVO : 62.63 (+2.17%)
OZEM : 24.23 (+3.11%)
LLY : 859.73 (+3.65%)
HRTS : 28.36 (+1.23%)
RHHBY : 39.7500 (+1.56%)
THNR : 21.12 (+2.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The Amplify Weight Loss Drug and Treatment ETF seeks investment results that generally correspond to the performance (before fees and expenses) of the VettaFi Weight Loss Drug and Treatment Index.

See More

Top 10 Holdings

Name % Holdings
Eli Lilly and Company 15.35%
Novo Nordisk A/S ADR 14.34%
N/A 5.49%
N/A 5.33%
West Pharmaceutical Services 5.28%
Amgen Inc 5.12%
N/A 4.89%
Astrazeneca Plc ADR 4.86%
Thermo Fisher Scientific Inc 4.83%
Pfizer Inc 4.80%

See More

Key Turning Points

3rd Resistance Point 21.26
2nd Resistance Point 21.19
1st Resistance Point 21.16
Last Price 21.12
1st Support Level 21.05
2nd Support Level 20.99
3rd Support Level 20.95

See More

52-Week High 28.19
Fibonacci 61.8% 24.51
Fibonacci 50% 23.38
Fibonacci 38.2% 22.24
Last Price 21.12
52-Week Low 18.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective